Nitric oxide synthase inhibitors and hypertension in children and adolescents

Journal of Hypertension

Volumn 15, Issue 8, 1997, Pages 901-909

  Goonasekera, Chulananda D A ^a,d   Rees, Daryl D ^b   Woolard, Patrick ^c   Frend, Anthony ^c   Shah, Vanita ^a   Dillon, Michael J ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Childhood hypertension; Methylated arginine analogues; Nitric oxide; Plasma renin activity; Renal function

Indexed keywords

CREATININE; DIMETHYLARGININE; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; PHENYLEPHRINE; RENIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD LEVEL; BLOOD VESSEL TONE; BODY HEIGHT; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 0030813303     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199715080-00015     Document Type: Article

References (58)

1. Rees DD, Palmer RMJ, Moncada S: Role of endothelium derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 1989, 86:3375-3378.
2. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991, 43: 109-142.
3. Moncada S: The L-arginine: nitric oxide pathway. Acta Physiol Scand 1992, 145:201-227.
4. Snyder SH, Bredt DS: Biological roles of nitric oxide. Scient Am 1992, 266:68-77.
5. Linder L, Kiowski W, Bühler FR, Lüscher TF: Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo: blunted response in essential hypertension. Circulation 1990, 81:1762-1767.
6. Panza JA, Quyyumi AA, Brush JE, Epstein SE: Abnormal endothelium-dependent relaxation in patients with essential hypertension. N Engl J Med 1990, 323:22-27.
7. G-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens 1992, 10:1025-1031.
8. Baylis C, Mitruka B, Deng A: Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 1992, 90:278-281.
9. Molnar M, Suto T, Toth T, Hertelendy F: Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. Am J Obstet Gynecol 1994, 170:1458-1466.
10. G-monomethyl-L-arginine uptake: a mechanism for differential inhibition of NO synthases? Am J Physiol 1995, 269:C750-C756.
11. Vallance P, Collier J, Moncada S: Effects of endothelium-derived nitric oxide on peripheral arterioler tone in man. Lancet 1989, ii:997-1000.
12. Salazar FJ, Alberola A, Pinilla JM, Romero JC, Quesada T: Salt-induced increase in arterial pressure during nitric oxide synthesis inhibition. Hypertension 1993, 22:49-55.
13. Baylis C, Mitruka B, Deng A: Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 1990, 90:278-281.
14. Fickling SA, Williams D, Vallance P, Nussey SS, Whitley GS: Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia. Lancet 1993, 342:242-243.
15. Seligman SP, Buyon JP, Clancy RM, Young BK, Abramson SB: The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol 1994, 171:944-948.
16. Yallampalli C, Garfield RE: Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol 1993, 169:1316-1320.
17. Vallance P, Leone A, Calver A, Collier J, Moncada S: Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992, 339:572-575.
18. Leumann EP: Blood pressure and hypertension in childhood and adolescence. Ergeb Inn Med Kinderheilk 1979, 43:109-183.
19. Rames LK, Clarke WR, Conner WE, Reiter MA, Lauer RM: Normal blood pressures and the evaluation of sustained blood pressure elevation in children. The Muscatine Study. Pediatrics 1978, 61:245-251.
20. Ingelfinger JR, Dillon MJ: Evaluation of secondary hypertension. In Pediatric Nephrology. Edited by Holliday MA, Barratt TM, Avner ED. Baltimore: Williams & Wilkins; 1994:1146-1164.
21. Johnson RA, Freeman RH: Renin release in rats during blockade of nitric oxide synthesis. Am J Physiol 1994, 266:R1723-R1729.
22. Persson PB, Baumann JE, Ehmke H, Hackenthal E, Kirchheim HR, Nafz B: Endothelium-derived NO stimulates pressure-dependent renin release in conscious dogs. Am J Physiol 1993, 264:F943-F947.
23. Sigmon DH, Carretero OA, Beierwaltes WH: Plasma renin activity and the renal response to nitric oxide synthesis inhibition. J Am Soc Nephrol 1992, 3:1288-1294.
24. Sigmon DH, Carretero OA, Beierwaltes WH: Endothelium derived relaxing factor regulates renin release in vivo. Am J Physiol 1992, 263:F256-F261.
25. Schricker K, Hegyi I, Hamann M, Kaissling B, Kurtz A: Tonic stimulation of renin gene expression by nitric oxide is counteracted by tonic inhibition through angiotensin II. Proc Natl Acad Sci USA 1995, 92:8006-8010.
26. Vidai MJ, Romeo JC, Vanhoutte PM: Endothelium-derived relaxing factor inhibits renin release. Eur J Pharmacol 1988, 149:401-402.
27. Grunskin AB, Dabbagh S, Fleischmann LE: Mechanisms of hypertension in childhood diseases. In Pediatric Nephrology. Edited by Holliday MA, Barratt TM, Avner ED. Baltimore: Williams & Wilkins; 1994:1096-1115.
28. Goonasekera CDA, Shah V, Wade AM, Barratt TM, Dillon MJ: 15-Year follow-up of renin and blood pressure in reflux nephropathy. Lancet 1996, 347:640-643.
29. National Heart, Lung and Blood Institute, Bethesda, Maryland: Report of the second task force on blood pressure control in children. Pediatrics 1987, 79:1-25.
30. Bartlet-Jones M, Jeffrey WA, Hansen HF, Pappin DJC: Peptide ladder sequencing by mass spectrometry using a novel, volatile degradation reagent Rapid Commun Mass Spectrom 1996, 8:737-742.
31. Dillon MJ: Measurement of plasma renin activity by semi-micro radioimmunoassay of generated angiotensin I. J Clin Pathol 1975, 28:625-630.
32. Morris MC, Allanby CW, Toseland P, Haycock GB, Chantier C: Evaluation of a height/plasma creatinine formula in the measurement of glomerular filtration rate. Arch Dis Child 1982, 57:611-615.
33. G dimethyl arginine from the hydrolysate of proteins of bovine brain. Biochem Biophys Acta 1971, 230:212-222.
34. Kakimoto Y, Matsuoka Y, Miyake M, Konishi H: Methylated amino acid residues of proteins of brain and other organs. J Neurochem 1975, 24:893-902.
35. G-dimethyl arginine, N-mono-, di-, and trimethyllysine, and glucosylgalactosyl- and galactosyl-gamma-hydroxylysine from human urine. J Biol Chem 1970, 245:5751-5758.
36. Carnegie PR, Fellows FCI, Symington GR: Urinary excretion of methylarginine in human disease. Metabolism 1977, 26:531-537.
37. Park KS, Lee HW, Hong SY, Shin S, Kim S, Paik WK: Determination of methylated aminoacids in human serum by high-performance liquid chromatography. J Chromatogr 1988, 440:225-230.
38. Ueno S, Sano A, Kotani K, Kondoh K, Kakimoto Y: Distribution of free methylarginines in rat tissues and in the bovine brain. J Neurochem 1992, 59:2012-2016.
39. Rees DD, Palmer RM, Schulz R, Hodson HF, Moncada S: Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 1990, 101:746-752.
40. G -dimethylarginines in multiple sclerosis patients: preliminary observations. J Neurol Sci 1995, 129:186-191.
41. Åneman A, Backman V, Snygg J, von Bothmer C, Fändriks L, Pettersson A: Accumulation of an endogenous inhibitor of nitric oxide synthase during graded hemorrhagic shock. Circulatory Shock 1995, 44:111-114.
42. Manning RDJ, Hu L, Mizelle HL, Montani JP, Norton MW: Cardiovascular responses to long-term blockade of nitric oxide synthesis. Hypertension 1993, 22:40-48.
43. MacAllister RJ, Fickling SA, Whitley GS, Vallance P: Metabolism of methylarginine by human vasculature: implications for regulation of nitric oxide synthesis. Br J Pharmacol 1994, 112:43-48.
44. Mann GE, Sheriff C, Toothill VJ, Pearson JD: Application of rapid dual tracer dilution techniques for the study of endothelial cell amino acid transport in perfused microcarrier cultures. In Cell Membrane Transport: Experimental Approaches and Methodologies. Edited by Yudilevich DL, Deves R, Peran S, Cabantchik ZI. New York: Plenum Press; 1991:451-469.
45. Bogle RG, Moncada S, Pearson JD, Mann GE: Identification of inhibitors of NO synthase that do not interact with the endothleial cell L-arginine transporter. Br J Pharmacol 1992, 105:768-770.
46. Schmidt K, Klatt P, Mayer B: Characterization of endothelial cell amino acid transport systems involved in the actions of nitric oxide synthase inhibitors. Mol Pharmacol 1993, 44:615-621.
47. G-dimethyl-L-arginine, a dominant precursor of endogenous dimethylamine in rats. Amino Acids 1994, 6:273-282.
48. G dimethyl arginine by human endothelial cells. Endothelium 1993, 1:137-140.
49. G-methylarginine requires NADPH-dependent hydroxylation. J Med Chem 1993, 36:491-496.
50. Scholz H, Kurtz A: Involvement of endothelium-derived relaxing factor in the pressure control of renin secretion from isolated perfused kidney. J Clin Invest 1993, 91:1088-1094.
51. Bachmann S, Mundel P: Nitric oxide in the kidney: synthesis, localization, and function [review]. Am J Kidney Dis 1994, 24:112-129.
52. Ribeiro MO, Antunes E, De Nucci G, Lovisolo SM, Zatz R: Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension 1992, 20:298-303.
53. Pollock DM, Polakowski JS, Divish BJ, Opgenorth TJ: Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition. Hypertension 1993, 21:660-666.
54. Chatziantoniou C, Pauti M, Pinet F, Promeneur D, Dussaule J, Ardaillou R: Regulation of renin release is impaired after nitric oxide inhibition. Kidney Int 1996, 49:626-633.
55. Arese M, Strasly M, Ruva C, Costamagna C, Ghigo D, MacAllister R, et al.: Regulation of nitric oxide synthesis in uraemia. Nephrol Dialysis Transplantation 1995, 10:1386-1397.
56. MacAllister PJ, Whitley GS, Vallance P: Effects of guanidino and uremic compounds on nitric oxide pathways. Kidney Int 1994, 45:737-742.
57. Davis PD, Parbrook GD, Kenny GNC: Basic Physics and Measurement in Anaesthesia. Oxford: Butterworth Heinemann; 1995:14-28.
58. Bank N, Aynedjian HS, Khan GA: Mechanism of vasoconstriction induced by chronic inhibition of nitric oxide in rats. Hypertension 1994, 24:322-328.